IDEAS home Printed from https://ideas.repec.org/r/oxp/obooks/9780199685028.html
   My bibliography  Save this item

Economic Evaluation in Clinical Trials

Citations

Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
as


Cited by:

  1. Drishti Shah & Lindsay Allen & Wanhong Zheng & Suresh S. Madhavan & Wenhui Wei & Traci J. LeMasters & Usha Sambamoorthi, 2021. "Economic Burden of Treatment-Resistant Depression among Adults with Chronic Non-Cancer Pain Conditions and Major Depressive Disorder in the US," PharmacoEconomics, Springer, vol. 39(6), pages 639-651, June.
  2. Claudia Schulz & Gisela Büchele & Raphael S. Peter & Dietrich Rothenbacher & Christian Brettschneider & Ulrich C. Liener & Clemens Becker & Kilian Rapp & Hans-Helmut König, 2021. "Health-economic evaluation of collaborative orthogeriatric care for patients with a hip fracture in Germany: a retrospective cohort study using health and long-term care insurance claims data," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 22(6), pages 873-885, August.
  3. Neill Booth & Pekka Rissanen & Teuvo L J Tammela & Paula Kujala & Ulf-Håkan Stenman & Kimmo Taari & Kirsi Talala & Anssi Auvinen, 2019. "Cost-effectiveness analysis of PSA-based mass screening: Evidence from a randomised controlled trial combined with register data," PLOS ONE, Public Library of Science, vol. 14(11), pages 1-17, November.
  4. Kristina R. Dahlstrom & Shuangshuang Fu & Wenyaw Chan & Zeena Shelal & Lois M. Ramondetta & David R. Lairson, 2018. "Medical Care Costs Associated with Genital Warts for Commercially Insured US Patients," PharmacoEconomics, Springer, vol. 36(11), pages 1355-1365, November.
  5. Maria Rubio-Valera & María Teresa Peñarrubia-María & Maria Iglesias-González & Martin Knapp & Paul McCrone & Marta Roig & Ramón Sabes-Figuera & Juan V. Luciano & Juan M. Mendive & Ana Gabriela Murruga, 2019. "Cost-effectiveness of antidepressants versus active monitoring for mild-to-moderate major depressive disorder: a multisite non-randomized-controlled trial in primary care (INFAP study)," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(5), pages 703-713, July.
  6. Charles Yan & Jeff Round & Ilke Akpinar & Chantal E. Atwood & Lesly Deuchar & Mohit Bhutani & Richard Leigh & Michael K. Stickland, 2023. "Cost Analysis of a Transition Care Bundle Compared with Usual Care for COPD Patients Being Discharged from Hospital: Evaluation of a Randomized Controlled Trial," PharmacoEconomics - Open, Springer, vol. 7(3), pages 493-505, May.
  7. José-Manuel Pastora-Bernal & María-José Estebanez-Pérez & Guadalupe Molina-Torres & Francisco-José García-López & Raquel Sobrino-Sánchez & Rocío Martín-Valero, 2021. "Telerehabilitation Intervention in Patients with COVID-19 after Hospital Discharge to Improve Functional Capacity and Quality of Life. Study Protocol for a Multicenter Randomized Clinical Trial," IJERPH, MDPI, vol. 18(6), pages 1-12, March.
  8. Long Khanh-Dao Le & Sophy Shih & Scott Richards-Jones & Mary Lou Chatterton & Lidia Engel & Christopher Stevenson & David Lawrence & Genevieve Pepin & Cathrine Mihalopoulos, 2021. "The cost of Medicare-funded medical and pharmaceutical services for mental disorders in children and adolescents in Australia," PLOS ONE, Public Library of Science, vol. 16(4), pages 1-16, April.
  9. Sarah J Stock & Margaret Horne & Merel Bruijn & Helen White & Kathleen A Boyd & Robert Heggie & Lisa Wotherspoon & Lorna Aucott & Rachel K Morris & Jon Dorling & Lesley Jackson & Manju Chandiramani & , 2021. "Development and validation of a risk prediction model of preterm birth for women with preterm labour symptoms (the QUIDS study): A prospective cohort study and individual participant data meta-analysi," PLOS Medicine, Public Library of Science, vol. 18(7), pages 1-22, July.
  10. José-Manuel Pastora-Bernal & Joaquín-Jesús Hernández-Fernández & María-José Estebanez-Pérez & Guadalupe Molina-Torres & Francisco-José García-López & Rocío Martín-Valero, 2021. "Efficacy, Feasibility, Adherence, and Cost Effectiveness of a mHealth Telerehabilitation Program in Low Risk Cardiac Patients: A Study Protocol," IJERPH, MDPI, vol. 18(8), pages 1-11, April.
  11. Cochrane, M. & Watson, P.M. & Timpson, H. & Haycox, A. & Collins, B. & Jones, L. & Martin, A. & Graves, L.E.F., 2019. "Systematic review of the methods used in economic evaluations of targeted physical activity and sedentary behaviour interventions," Social Science & Medicine, Elsevier, vol. 232(C), pages 156-167.
  12. Kathrin Steinbeisser & Larissa Schwarzkopf & Elmar Graessel & Hildegard Seidl, 2020. "Cost-effectiveness of a non-pharmacological treatment vs. “care as usual” in day care centers for community-dwelling older people with cognitive impairment: results from the German randomized controll," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(6), pages 825-844, August.
  13. NamKwen Kim & Kyung-Min Shin & Eun-Sung Seo & Minjung Park & Hye-Yoon Lee, 2020. "Electroacupuncture with Usual Care for Patients with Non-Acute Pain after Back Surgery: Cost-Effectiveness Analysis Alongside a Randomized Controlled Trial," Sustainability, MDPI, vol. 12(12), pages 1-13, June.
  14. Florian Kirsch & Christian Becker & Anja Schramm & Werner Maier & Reiner Leidl, 2020. "Patients with coronary artery disease after acute myocardial infarction: effects of continuous enrollment in a structured Disease Management Program on adherence to guideline-recommended medication, h," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(4), pages 607-619, June.
  15. Ilias Goranitis & Leana Bellanca & Amanda J Daley & Adele Thomas & Helen Stokes-Lampard & Andrea K Roalfe & Sue Jowett, 2017. "Aerobic exercise for vasomotor menopausal symptoms: A cost-utility analysis based on the Active Women trial," PLOS ONE, Public Library of Science, vol. 12(9), pages 1-15, September.
  16. Jalal Dahham & Ingrid Kremer & Mickaël Hiligsmann & Kamal Hamdan & Abdallah Nassereddine & Silvia M. A. A. Evers & Rana Rizk, 2023. "Valuation of Costs in Health Economics During Financial and Economic Crises: A Case Study from Lebanon," Applied Health Economics and Health Policy, Springer, vol. 21(1), pages 31-38, January.
  17. Khavjou, Olga & Forehand, Rex & Loiselle, Raelyn & Turner, Patrick & Buell, Naomi & Jones, Deborah J., 2020. "Helping the noncompliant child: An updated assessment of program costs and cost-effectiveness," Children and Youth Services Review, Elsevier, vol. 114(C).
  18. Jamie O’Hara & Shaun Walsh & Charlotte Camp & Giuseppe Mazza & Liz Carroll & Christina Hoxer & Lars Wilkinson, 2018. "The relationship between target joints and direct resource use in severe haemophilia," Health Economics Review, Springer, vol. 8(1), pages 1-7, December.
  19. Dikshyanta Rana & Claudia Geue & Kelly Baillie & Jiafeng Pan & Tanja Mueller & Jennifer Laskey & Marion Bennie & Julie Clarke & Robert J. Jones & Ailsa Brown & Olivia Wu, 2022. "Healthcare Costs for Metastatic Castration-Resistant Prostate Cancer Patients Treated with Abiraterone or Enzalutamide," PharmacoEconomics - Open, Springer, vol. 6(2), pages 303-313, March.
  20. Thathya V. Ariyaratne & Zanfina Ademi & Molla Huq & Franklin Rosenfeldt & Stephen J. Duffy & Bonny Parkinson & Cheng-Hon Yap & Julian Smith & Baki Billah & Bryan P. Yan & Angela L. Brennan & Lavinia T, 2018. "The Real-World Cost-Effectiveness of Coronary Artery Bypass Surgery Versus Stenting in High-Risk Patients: Propensity Score-Matched Analysis of a Single-Centre Experience," Applied Health Economics and Health Policy, Springer, vol. 16(5), pages 661-674, October.
  21. Osvaldo Ulises Garay & Marie Libérée Nishimwe & Marwân-al-Qays Bousmah & Asmaa Janah & Pierre-Marie Girard & Geneviève Chêne & Laetitia Moinot & Luis Sagaon-Teyssier & Jean-Luc Meynard & Bruno Spire &, 2019. "Cost-Effectiveness Analysis of Lopinavir/Ritonavir Monotherapy Versus Standard Combination Antiretroviral Therapy in HIV-1 Infected Patients with Viral Suppression in France (ANRS 140 DREAM)," PharmacoEconomics - Open, Springer, vol. 3(4), pages 505-515, December.
  22. S. Boyer & M. L. Nishimwe & L. Sagaon-Teyssier & L. March & S. Koulla-Shiro & M.-Q. Bousmah & R. Toby & M. P. Mpoudi-Etame & N. F. Ngom Gueye & A. Sawadogo & C. Kouanfack & L. Ciaffi & B. Spire & E. D, 2020. "Cost-Effectiveness of Three Alternative Boosted Protease Inhibitor-Based Second-Line Regimens in HIV-Infected Patients in West and Central Africa," PharmacoEconomics - Open, Springer, vol. 4(1), pages 45-60, March.
  23. Marwân-al-Qays Bousmah & Marie Libérée Nishimwe & Tamara Tovar-Sanchez & Martial Lantche Wandji & Mireille Mpoudi-Etame & Gwenaëlle Maradan & Pierrette Omgba Bassega & Marie Varloteaux & Alice Montoyo, 2021. "Cost-Utility Analysis of a Dolutegravir-Based Versus Low-Dose Efavirenz-Based Regimen for the Initial Treatment of HIV-Infected Patients in Cameroon (NAMSAL ANRS 12313 Trial)," PharmacoEconomics, Springer, vol. 39(3), pages 331-343, March.
  24. Annabel Sandra Mueller-Stierlin & Uemmueguelsuem Dinc & Katrin Herder & Julia Walendzik & Matthias Schuetzwohl & Thomas Becker & Reinhold Kilian, 2022. "The Cost-Effectiveness Analysis of an Integrated Mental Health Care Programme in Germany," IJERPH, MDPI, vol. 19(11), pages 1-14, June.
  25. A-La Park & Eui-Hyoung Hwang & Man-Suk Hwang & In Heo & Sun-Young Park & Jun-Hwan Lee & In-Hyuk Ha & Jae-Heung Cho & Byung-Cheul Shin, 2021. "Cost-Effectiveness of Chuna Manual Therapy and Usual Care, Compared with Usual Care Only for People with Neck Pain following Traffic Accidents: A Multicenter Randomized Controlled Trial," IJERPH, MDPI, vol. 18(19), pages 1-13, September.
  26. Carlo Lazzaro & Cecile van Steen & Florent Aptel & Cedric Schweitzer & Luigi Angelillo, 2022. "Cost-Utility Analysis of STN1013001, a Latanoprost Cationic Emulsion, versus Other Latanoprost Formulations (Latanoprost) in Open-Angle Glaucoma or Ocular Hypertension and Ocular Surface Disease in Fr," Post-Print hal-03696350, HAL.
  27. Matthew Franklin & James Lomas & Simon Walker & Tracey Young, 2019. "An Educational Review About Using Cost Data for the Purpose of Cost-Effectiveness Analysis," PharmacoEconomics, Springer, vol. 37(5), pages 631-643, May.
  28. Seghieri, Chiara & Berta, Paolo & Nuti, Sabina, 2019. "Geographic variation in inpatient costs for Acute Myocardial Infarction care: Insights from Italy," Health Policy, Elsevier, vol. 123(5), pages 449-456.
IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.